Sacubitril/valsartan, ivabradine hydrochloride, alirocumab, and evolocumab

Autor: Hussar, Daniel A., Abdelsayed, Marina
Zdroj: In Journal of the American Pharmacists Association November-December 2015 55(6):674-678
Databáze: ScienceDirect